- Home
- PRTH vs KALV Comparison
PRTH vs KALV Comparison
Compare PRTH & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTH
- KALV
- Stock Information
- Founded
- PRTH 2005
- KALV N/A
- Country
- PRTH United States
- KALV United States
- Employees
- PRTH N/A
- KALV N/A
- Industry
- PRTH EDP Services
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- PRTH Technology
- KALV Health Care
- Exchange
- PRTH Nasdaq
- KALV Nasdaq
- Market Cap
- PRTH 687.1M
- KALV 563.1M
- IPO Year
- PRTH N/A
- KALV N/A
- Fundamental
- Price
- PRTH $7.22
- KALV $12.73
- Analyst Decision
- PRTH Strong Buy
- KALV Strong Buy
- Analyst Count
- PRTH 4
- KALV 8
- Target Price
- PRTH $12.75
- KALV $24.83
- AVG Volume (30 Days)
- PRTH 462.4K
- KALV 653.3K
- Earning Date
- PRTH 05-08-2025
- KALV 03-12-2025
- Dividend Yield
- PRTH N/A
- KALV N/A
- EPS Growth
- PRTH N/A
- KALV N/A
- EPS
- PRTH N/A
- KALV N/A
- Revenue
- PRTH $879,702,000.00
- KALV N/A
- Revenue This Year
- PRTH $12.87
- KALV N/A
- Revenue Next Year
- PRTH $10.49
- KALV N/A
- P/E Ratio
- PRTH N/A
- KALV N/A
- Revenue Growth
- PRTH 16.42
- KALV N/A
- 52 Week Low
- PRTH $3.06
- KALV $7.30
- 52 Week High
- PRTH $12.47
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- PRTH 49.76
- KALV 59.37
- Support Level
- PRTH $6.45
- KALV $12.10
- Resistance Level
- PRTH $7.30
- KALV $12.69
- Average True Range (ATR)
- PRTH 0.54
- KALV 0.90
- MACD
- PRTH 0.14
- KALV 0.11
- Stochastic Oscillator
- PRTH 93.80
- KALV 89.68
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium businesses enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments and Enterprise Payments. SMB Payments segment which generates majority revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging priority's proprietary software platform, distributed through ISO; B2B Payments segment provides AP automation solutions to corporations, software partners and industry FIs: and Enterprise Payments segment provides embedded payment and treasury solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.